These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30244058)

  • 1. A provider global assessment quality measure for clinical practice for inflammatory skin disorders.
    Gottlieb A; Salame N; Armstrong AW; Merola JF; Parra S; Takeshita J; Chen SC; Latella J; Van Beek M;
    J Am Acad Dermatol; 2019 Mar; 80(3):823-828. PubMed ID: 30244058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders.
    Perez-Chada L; Taliercio VL; Gottlieb AB; Van Beek M; Duffin KC; Reeder M; Merola JF; Swerlick RA; ;
    J Am Acad Dermatol; 2023 Jan; 88(1):86-93. PubMed ID: 31525439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of healthcare quality in atopic dermatitis - development and application of a set of quality indicators.
    Steinke S; Beikert FC; Langenbruch A; Fölster-Holst R; Ring J; Schmitt J; Werfel T; Hintzen S; Franzke N; Augustin M
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2237-2243. PubMed ID: 29763514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of traditional Chinese medicine in some dermatologic diseases: Part I--Acne, psoriasis, and atopic dermatitis.
    Baroni A; Ruocco E; Russo T; Piccolo V; Geng L; Zhou H; Chen HD; Gao XH
    Skinmed; 2015; 13(1):32-8; quiz 39. PubMed ID: 25842471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.
    Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What should primary care providers know about pediatric skin conditions? A modified Delphi technique for curriculum development.
    Feigenbaum DF; Boscardin CK; Frieden IJ; Mathes EF
    J Am Acad Dermatol; 2014 Oct; 71(4):656-62. PubMed ID: 25087213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes.
    Pascoe VL; Enamandram M; Corey KC; Cheng CE; Javorsky EJ; Sung SM; Donahue KR; Kimball AB
    JAMA Dermatol; 2015 Apr; 151(4):375-81. PubMed ID: 25549367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative.
    Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW
    Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Indicators in Care of Patients With Atopic Dermatitis: Consensus Document of the Spanish Academy of Dermatology and Venereology.
    Poveda-Montoyo I; García-Doval I; Descalzo MA; Betlloch-Mas I; Miquel-Miquel FJ; Serrano-Manzano M; Martín-Delgado MI; Sanz-Sánchez T; Knöpfel N; Córdoba S; Luca de Tena A; Martín-Santiago A; Silvestre JF
    Actas Dermosifiliogr (Engl Ed); 2020 Sep; 111(7):567-573. PubMed ID: 32401727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and real-world solutions for adoption of holistic skincare routine (cleansing, treatment, moisturization, and photoprotection) in acne, rosacea, atopic dermatitis, and sensitive skin: An expert consensus.
    Goh CL; Wu Y; Welsh B; Abad-Casintahan MF; Tseng CJ; Sharad J; Jung S; Puangpet P; Chan HNK; Kon K
    J Cosmet Dermatol; 2024 Aug; 23(8):2516-2523. PubMed ID: 38853652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study.
    Salgado-Boquete L; Arias-Santiago S; Belinchón-Romero I; de la Cuadra-Grande A; de la Cueva P; Gilaberte Y; Notario J; Rivera-Díaz R; Ruiz-Villaverde R; Carrascosa JM;
    Actas Dermosifiliogr; 2023; 114(10):865-883. PubMed ID: 36796538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common dermatoses.
    Nanda VS
    Am J Obstet Gynecol; 1995 Aug; 173(2):488-95. PubMed ID: 7645626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential barriers to adherence in pediatric dermatology.
    Ellis RM; Koch LH; McGuire E; Williams JV
    Pediatr Dermatol; 2011; 28(3):242-4. PubMed ID: 21615470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acne severity grading: determining essential clinical components and features using a Delphi consensus.
    Tan J; Wolfe B; Weiss J; Stein-Gold L; Bikowski J; Del Rosso J; Webster GF; Lucky A; Thiboutot D; Wilkin J; Leyden J; Chren MM
    J Am Acad Dermatol; 2012 Aug; 67(2):187-93. PubMed ID: 22036609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.
    Gottlieb AB; Levin AA; Armstrong AW; Abernethy A; Duffin KC; Bhushan R; Garg A; Merola JF; Maccarone M; Christensen R
    J Am Acad Dermatol; 2015 Feb; 72(2):345-8. PubMed ID: 25486914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
    Simpson E; Bissonnette R; Eichenfield LF; Guttman-Yassky E; King B; Silverberg JI; Beck LA; Bieber T; Reich K; Kabashima K; Seyger M; Siegfried E; Stingl G; Feldman SR; Menter A; van de Kerkhof P; Yosipovitch G; Paul C; Martel P; Dubost-Brama A; Armstrong J; Chavda R; Frey S; Joubert Y; Milutinovic M; Parneix A; Teixeira HD; Lin CY; Sun L; Klekotka P; Nickoloff B; Dutronc Y; Mallbris L; Janes JM; DeLozier AM; Nunes FP; Paller AS
    J Am Acad Dermatol; 2020 Sep; 83(3):839-846. PubMed ID: 32344071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory dermatoses in skin of color].
    Ludwig RJ; von Stebut E
    Dermatologie (Heidelb); 2023 Feb; 74(2):84-89. PubMed ID: 36592194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.
    Bostoen J; Bracke S; De Keyser S; Lambert J
    Br J Dermatol; 2012 Nov; 167(5):1025-31. PubMed ID: 22709422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Ribera M; Hernanz JM; Belinchón I; Santos-Juanes J; Linares M; Querol I; Colomé E; Caballé G
    Actas Dermosifiliogr; 2010 Dec; 101(10):827-46. PubMed ID: 21159259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
    Steinke S; Zeidler C; Riepe C; Bruland P; Soto-Rey I; Storck M; Augustin M; Bobko S; Garcovich S; Legat FJ; Lvov A; Misery L; Osada N; Reich A; Şavk E; Serra-Baldrich E; Streit M; Szepietowski JC; Weger W; Dugas M; Ständer S
    J Am Acad Dermatol; 2018 Sep; 79(3):457-463.e5. PubMed ID: 30119869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.